The largest database of trusted experimental protocols

Spss release 18

Manufactured by IBM
Sourced in United States

SPSS 18.0 is a statistical software package developed by IBM. It provides tools for data analysis, data management, and data visualization. The software is designed to help users analyze and interpret data from a variety of sources, including surveys, experiments, and observational studies.

Automatically generated - may contain errors

Lab products found in correlation

9 protocols using spss release 18

1

Survival Outcomes in Clinical Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
The primary outcome assessed in this study was survival. Categorical variables were compared using χ2 or Fisher’s exact tests, and continuous variables were evaluated using Student’s t test. P values of less than 0.05 were regarded as significant. Statistical analyses were performed using SPSS release 18 (SPSS Inc., Chicago, Ill), and all statistical tests were two-sided.
+ Open protocol
+ Expand
2

Statistical Analysis of Image Quality

Check if the same lab product or an alternative is used in the 5 most similar protocols
A statistical analysis was conducted by using a commercially available statistical program (SPSS, release 18; SPSS Inc., Chicago, IL, USA). Due to the small number of the variables, non-parametric tests were used for the statistical analysis. Image noise, SNR, and CNR among different radiation dose levels and reconstruction algorithms were compared by using Friedman tests with pair-wise post-hoc Wilcoxon signed rank. In addition, image noise differences among different tube voltages were compared by using Kruskal-Wallis tests with pair-wise post-hoc Mann-Whitney U-tests. A p value < 0.05 was considered statistically significant, and the Bonferroni correction was used to avoid an inflation of alpha error due to multiple comparisons.
+ Open protocol
+ Expand
3

Statistical Analysis of Biometric Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analysis was performed using SPSS release 18 (SPSS Inc, Chicago, IL, USA) software. Data are presented as the mean ± standard deviation (SD). The comparison between continuous variables of the two groups was performed through ANOVA. Least squares linear regression was used to evaluate univariate correlates of a given variable. Multiple linear regression analyses were used to identify the independent contributors of variables in the pooled population. Collinearity was considered acceptable and regression model stable for variance inflation factor <3. Differences between groups were considered significant when p < 0.05.
+ Open protocol
+ Expand
4

Statistical Analysis of Treatment Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
The statistical analyses were carried out using SPSS Release 18 for Windows. Tukey’s HSD test at the P ≤ 0.05 was chosen to determine significant differences between treatments. Small letters on top of bars point the significant differences between treatments.
+ Open protocol
+ Expand
5

Dexamethasone Pharmacokinetics Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tissue concentration data are expressed in nanograms per gram or nanograms per milliliter. Pharmacokinetic parameters were analyzed with a commercial software (Kinetica 5.1; Innaphase, Philadelphia, PA) by fitting the data to the Extravascular analysis model, and non-compartmental parameters were calculated and reported. Maximum concentration (Cmax), time to maximum concentration (Tmax), elimination half-life (T1/2), the area under the concentration–time curve AUC0–n were obtained. Statistical analysis was performed using SPSS release 18.0 (SPSS Chicago, IL). Dexamethasone concentrations were analyzed for normality by using K-S test and parametric or nonparametric tests were used as appropriate.
+ Open protocol
+ Expand
6

Evaluating Pain Relief Interventions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Obtained data is analyzed using SPSS (Release 18.0, SPSS Inc., Chicago, IL, USA).
Baseline characteristics of studied population were compared using Student t-test and Chi-square test. DN4 score in the placebo and intervention groups before and after the intervention was compared using Mcnemar test. Mean ± standard deviation (SD) of NPS score in the placebo and intervention groups before and after the intervention was compared using independent and paired t-tests. P < 0.05 was considered to be statistically significant.
+ Open protocol
+ Expand
7

Effects of Exercise Intensity on Metabolic Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data are expressed as the mean ± standard deviation. The normal Gaussian distribution was verified by the Shapiro-Wilk test, whereas homogeneity of variance was assessed using Levene's test. Inter- and intra-group comparisons of the variables were computed by two-way ANOVA (group vs. time) with repeated measurements to determine the main and interaction effects between groups over time. Percentage change between pre-test and post-test was calculated for each parameter. One-way ANOVA was used to determine the difference of the percentage change between groups (MIIT, HIIT and control group). Whenever significant differences in values occurred, a pair-wise multiple comparisons test was performed using a Bonferroni post-hoc test. In addition, post-hoc effect size statistics (ES) for all the statistically significant t ratios were established. These calculations were based on Cohen's classification, and knowledge of the ES enabled the magnitude of the difference to be estimated (i.e., trivial: ES < 0.2, small: 0.2 ≤ ES < 0.5, moderate: 0.5 ≤ ES < 0.8, or large: ES ≥ 0.8).
In order to identify the most relevant associations, stepwise multiple regression was performed, while the correlation between leptin and other parameters was examined using Pearson's test.
Statistical significance was set at p<0.05, and all analyses were performed with SPSS (release 18.0, Chicago, IL, USA).
+ Open protocol
+ Expand
8

CO2 Levels and Hospital Length of Stay

Check if the same lab product or an alternative is used in the 5 most similar protocols
All analyses were conducted using the Statistical Package for Social Science (SPSS) release 18.0, standard version (1989–02). A descriptive analysis of demographic features is presented as mean±SD for quantitative variables (ie, age, LOS and LOS in the hypocapnia, hypercapnia and normocapnia groups) and number (%) for qualitative variables (ie, gender, mortality, hypocapnia, hypercapnia and normopcania and mortality in hypocapnia, hypercapnia and normocapnia groups). A χ2 test was used to compare the mortality in the three groups and ANOVA was used for mean LOS in the three groups. Due to the skewed distribution of LOS, it was categorised for the main analysis. LOS was dichotomised into mean <7 days and >7 days. ORs and their 95% CIs were estimated using logistic regression with LOS as the outcome variable. Kaplan–Meier plot analysis was done to assess LOS among the three PaCO2 groups. All significant factors in the univariate analysis were considered for inclusion in the multivariable logistic model. All p values were two-sided and p values ≤0.05 were taken as significant.
+ Open protocol
+ Expand
9

Experimental Procedure for Statistical Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experiments were repeated for at least three times. Data were expressed as mean ± SD and analyzed with the Statistical Package for the Social Sciences (SPSS Release 18.0, SPSS Inc., Chicago, IL, USA). Differences were evaluated using a two-way analysis of variance (ANOVA), followed by Bonferonni posttest. A P-value less than 0.05 was considered as statistically, significantly different.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!